Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junxing Shi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
2('),3(')-didehydro-2('),3(')-dideoxynucleosides are degraded to furfuryl alcohol under acidic conditionsJunxing Shi, Adrian S Ray, Judy S Mathew, et al.
Biochemistry|April 17, 2002
Insights into the molecular mechanism of inhibition and drug resistance for HIV-1 RT with carbovir triphosphateAdrian S Ray, Zhenjun Yang, Junxing Shi, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitorOmar N Al Safarjalani, Reem Rais, Junxing Shi, et al.
Antiviral Chemistry & Chemotherapy|October 3, 2003
Probing the mechanistic consequences of 5-fluorine substitution on cytidine nucleotide analogue incorporation by HIV-1 reverse transcriptaseAdrian S Ray, Raymond F Schinazi, Eisuke Murakami, et al.
Antiviral Chemistry & Chemotherapy|July 12, 2005
Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosidesS Balakrishna Pai, Rekha B Pai, Meng-yu Xie, et al.
The Journal of Organic Chemistry|August 1, 2009
An efficient and diastereoselective synthesis of PSI-6130: a clinically efficacious inhibitor of HCV NS5B polymerasePeiyuan Wang, Byoung-Kwon Chun, Suguna Rachakonda, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2005
5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimensOmar N Al Safarjalani, Xiao-Jian Zhou, Reem H Rais, et al.
Nucleosides, Nucleotides & Nucleic Acids|November 8, 2005
N4-hydroxycytosine dioxolane nucleosides and their activity against hepatitis B virusJinfa Du, Laurent Hollecker, Junxing Shi, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2012
Synthesis and evaluation of novel potent HCV NS5A inhibitorsHongwang Zhang, Longhu Zhou, Franck Amblard, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2012
Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitorsJunxing Shi, Longhu Zhou, Franck Amblard, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
2('),3(')-didehydro-2('),3(')-dideoxynucleosides are degraded to furfuryl alcohol under acidic conditionsJunxing Shi, Adrian S Ray, Judy S Mathew, et al.
Biochemistry|April 17, 2002
Insights into the molecular mechanism of inhibition and drug resistance for HIV-1 RT with carbovir triphosphateAdrian S Ray, Zhenjun Yang, Junxing Shi, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2006
Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitorOmar N Al Safarjalani, Reem Rais, Junxing Shi, et al.
Antiviral Chemistry & Chemotherapy|October 3, 2003
Probing the mechanistic consequences of 5-fluorine substitution on cytidine nucleotide analogue incorporation by HIV-1 reverse transcriptaseAdrian S Ray, Raymond F Schinazi, Eisuke Murakami, et al.
Antiviral Chemistry & Chemotherapy|July 12, 2005
Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosidesS Balakrishna Pai, Rekha B Pai, Meng-yu Xie, et al.
The Journal of Organic Chemistry|August 1, 2009
An efficient and diastereoselective synthesis of PSI-6130: a clinically efficacious inhibitor of HCV NS5B polymerasePeiyuan Wang, Byoung-Kwon Chun, Suguna Rachakonda, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2005
5-(Phenylthio)acyclouridine: a powerful enhancer of oral uridine bioavailability: relevance to chemotherapy with 5-fluorouracil and other uridine rescue regimensOmar N Al Safarjalani, Xiao-Jian Zhou, Reem H Rais, et al.
Nucleosides, Nucleotides & Nucleic Acids|November 8, 2005
N4-hydroxycytosine dioxolane nucleosides and their activity against hepatitis B virusJinfa Du, Laurent Hollecker, Junxing Shi, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2012
Synthesis and evaluation of novel potent HCV NS5A inhibitorsHongwang Zhang, Longhu Zhou, Franck Amblard, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2012
Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitorsJunxing Shi, Longhu Zhou, Franck Amblard, et al.
Pageof 3